These insights highlight that the implications of TDP-43 extend beyond prognostication, with therapeutic relevance not only for ALS but also for other TDP-43 related neurodegenerative diseases such as LATE9, AD10,11, and AD with hippocampal sclerosis12. This evidence concerns the gene TARDBP and Alzheimer disease.